Invenio Imaging

Invenio Imaging

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://www.invenio-imaging.com/

Last Round

VC Round

Jan 29, 2026

Total Funding Raised

$4.21M

Momentum Score

25 /100

Company Overview

Invenio Imaging is a medical device company that develops and manufactures an imaging system for intraoperative histology. The company's NIO® Laser Imaging System uses Stimulated Raman Histology (SRH) and artificial intelligence to provide real-time, high-resolution images of fresh tissue samples during surgical procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

Stimulated Raman HistologySRHintraoperative imagingreal-time histologymedical devicesurgical AItumor margin assessmentoptical biopsyfresh tissue imagingdigital pathologyfrozen section alternativelabel-free imagingAI medical imagingcancer surgery technologyneurosurgery technologyinterventional pulmonology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Invenio Imaging Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Invenio Imaging Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 29, 2026
GrantMar 1, 2023
GrantSep 1, 2022
Series AJan 8, 2019
SeedDec 29, 2015
Grant
Jul 1, 2013

Key People

Founding team and executive leadership

Christian Freudiger

Co-Founder And CTO

Founding Team

Jay Trautman

Co-Founder, Chief Executive Officer & Director

Founding Team

Invenio Imaging Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    Michigan Biomedical Venture Fund participated in the round.

  • Mar 1, 2023

    $2M grant from National Cancer Institute and NIH RADx.

Invenio Imaging Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Invenio Imaging Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Invenio Imaging's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range18
Year Founded2012
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.